e-learning
resources
London 2016
Tuesday, 06.09.2016
How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Optimization of cfDNA routine use for NSCLC genomic alteration analysis
Pascale Tomasini (Marseille, France), Pascale Tomasini, Frederic Fina, Clotilde Fournier, Laurent Greillier, L’Houcine Ouafik, Celine Mascaux, Fabrice Barlesi
Source:
International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Session:
How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Session type:
Poster Discussion
Number:
3417
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Pascale Tomasini (Marseille, France), Pascale Tomasini, Frederic Fina, Clotilde Fournier, Laurent Greillier, L’Houcine Ouafik, Celine Mascaux, Fabrice Barlesi. Optimization of cfDNA routine use for NSCLC genomic alteration analysis. Eur Respir J 2016; 48: Suppl. 60, 3417
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Comparative analysis of lung cancer driver mutations from FFPE samples and liquid biopsies by IonTorrent next generation sequencing
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP)
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013
RT-PCR and IHC as the alternative methods for detection of ALK aberrations in NSCLC samples - The feasibility study
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Plasma cell-free DNA concentration and integrity analysis in patients with chest radiological findings: NSCLC versus non-malignant pathologies
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Automated target-FISH lung cancer detection (LCD) test of induced sputum
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Exploiting metabolomic approaches to aid in the diagnosis of lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Allele-specific real-time PCR detection of EGFR exon 19 and 21 mutations in various clinical non-small cell lung cancer specimens
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Prevalence of molecular changes in resected pulmonary adenocarcinomas
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
High-throughput detection of alternative splicing in patients with non-small cell lung cancer treated by bevacizumab/erlotinib
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014
Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level?
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Determining genomic rearrangements in clinical lung specimens for assessment of metastatic disease, actionable targets and disease monitoring
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
The methylation profiling of multiple tumor suppressor genes in plasma cell-free DNA from patients with NSCLC versus non-malignant tumors - pilot study
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
Metabolomic analysis of serum samples from patients with lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014
Early response detection in systemic lung cancer treatment using cell-free methylated SHOX2 (mSHOX2) plasma DNA
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Expression analysis of miR-21 in Bulgarian patients with non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Quantitative detection of ALK rearrangements using droplet digital PCR (ddPCR) in liquid biopsies of patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
Molecular profiling of lung squamous carcinogenesis
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept